Mcrae Capital Management Inc Pfizer Inc Transaction History

Mcrae Capital Management Inc

$419 Million
Q2 2024

A detailed history of Mcrae Capital Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Mcrae Capital Management Inc holds 39,280 shares of PFE stock, worth $1.12 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

39,280

Previous 41,980 6.43%

Holding current value

$1.12 Million

Previous $1.16 Million 5.58%

% of portfolio

0.26%

Previous 0.26%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	SELL	$25.26 - $29.6 $68,202 - $79,920	-2,700 Reduced 6.43%	39,280 $1.1 Million
Q2 2023 Jul 21, 2023	BUY	$36.12 - $41.79 $10,836 - $12,537	300 Added 0.72%	41,980 $1.54 Million
Q1 2023 Apr 19, 2023	SELL	$39.39 - $51.28 $19,695 - $25,640	-500 Reduced 1.19%	41,680 $1.7 Million
Q4 2022 Jan 20, 2023	SELL	$41.75 - $54.5 $58,450 - $76,300	-1,400 Reduced 3.21%	42,180 $0
Q3 2022 Oct 20, 2022	BUY	$43.76 - $53.42 $1,137 - $1,388	26 Added 0.06%	43,580 $1.91 Million
Q2 2022 Jul 20, 2022	BUY	$46.53 - $55.17 $47,832 - $56,714	1,028 Added 2.42%	43,554 $2.28 Million
Q1 2022 Apr 21, 2022	BUY	$45.75 - $56.69 $64,370 - $79,762	1,407 Added 3.42%	42,526 $2.2 Million
Q3 2021 Oct 26, 2021	SELL	$39.25 - $50.42 $6,280 - $8,067	-160 Reduced 0.39%	41,119 $1.77 Million
Q1 2021 May 11, 2021	BUY	$33.49 - $37.77 $4,789 - $5,401	143 Added 0.35%	41,279 $1.5 Million
Q4 2020 Jan 27, 2021	BUY	$33.47 - $42.56 $1.01 Million - $1.29 Million	30,236 Added 277.39%	41,136 $1.51 Million
Q3 2020 Nov 09, 2020	SELL	$31.75 - $37.25 $57,150 - $67,050	-1,800 Reduced 14.17%	10,900 $400,000
Q1 2020 Apr 16, 2020	SELL	$27.03 - $38.62 $86,090 - $123,004	-3,185 Reduced 20.05%	12,700 $415,000
Q3 2019 Oct 21, 2019	BUY	$32.49 - $42.13 $1,137 - $1,474	35 Added 0.22%	15,885 $571,000
Q2 2019 Jul 29, 2019	SELL	$36.98 - $41.52 $11,057 - $12,414	-299 Reduced 1.85%	15,850 $687,000
Q1 2019 Apr 16, 2019	SELL	$37.5 - $41.2 $135,937 - $149,350	-3,625 Reduced 18.33%	16,149 $686,000
Q4 2018 Jan 28, 2019	SELL	$38.47 - $43.86 $11,541 - $13,158	-300 Reduced 1.49%	19,774 $863,000
Q3 2018 Oct 15, 2018	SELL	$34.47 - $41.81 $2.16 Million - $2.62 Million	-62,759 Reduced 75.77%	20,074 $885,000
Q2 2018 Jul 16, 2018	BUY	$32.98 - $35.16 $2.08 Million - $2.21 Million	62,937 Added 316.33%	82,833 $3.01 Million
Q1 2018 May 09, 2018	SELL	$31.91 - $37.02 $1.72 Million - $1.99 Million	-53,769 Reduced 72.99%	19,896 $706,000
Q4 2017 Feb 13, 2018	BUY	$33.26 - $35.29 $2.12 Million - $2.25 Million	63,704 Added 639.53%	73,665 $2.67 Million
Q3 2017 Oct 23, 2017	BUY	$31.0 - $34.15 $308,791 - $340,168	9,961	9,961 $356,000

Others Institutions Holding PFE

# of Institutions

3,216

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $160B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcrae Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mcrae Capital Management Inc with notifications on news.

Account

Mcrae Capital Management Inc Pfizer Inc Transaction History